Objectives

After participating in this educational activity, attendees should be able to:
1| Describe cardiac surgery-associated AKI and the rationale for SGLT2 inhibition.

2| Evaluate the design and results of the MERCURI-2 trial.

3| Assess the clinical significance, safety, and potential role of perioperative dapagliflozin

Presenter(s): 
Nicole Servetnik, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Nicole Servetnik, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
10/12/2026 - 2:30pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 0.50 ACPE Contact Hours
  • 0.50 ACPE Technician contact hours
Please login or register to take this course.